TY - JOUR
T1 - Risk Factors for Non-Ampullary Duodenal Adenocarcinoma
T2 - A Systematic Review
AU - Yabuuchi, Yohei
AU - Yoshida, Masao
AU - Kakushima, Naomi
AU - Kato, Motohiko
AU - Iguchi, Mikitaka
AU - Yamamoto, Yorimasa
AU - Kanetaka, Kengo
AU - Uraoka, Toshio
AU - Fujishiro, Mitsuhiro
AU - Sho, Masayuki
N1 - Funding Information:
This study was supported by Sciences Research Grant from the Japanese Ministry of Health, Labor, and Welfare.
Publisher Copyright:
© 2022 S. Karger AG, Basel.
PY - 2022/2/1
Y1 - 2022/2/1
N2 - Introduction: An increase in the incidence of duodenal adenocarcinoma has been recently reported. However, little is known about the risk factors for duodenal adenocarcinoma, which are important for screening purposes. We, therefore, aimed to conduct a systematic review to identify risk factors for non-ampullary duodenal adenocarcinoma. Methods: A medical literature search was performed using electronic databases, including PubMed, Cochrane Library, Japan Medical Abstracts Society, and Web of Science. Studies that assessed the association between dietary habits, lifestyle behaviors, comorbidities, and non-ampullary duodenal adenocarcinoma were extracted. The Newcastle-Ottawa Scale was used to assess the risk of bias in individual studies, and the Grading of Recommendations, Assessment, Development, and Evaluations approach was used to assess the quality of evidence across studies included in this review. Results: Out of 1,244 screened articles, 10 were finally selected for qualitative synthesis. In the general population, no consistent risk factors were identified except for Helicobacter pylori positivity, which was considered a risk factor in 2 studies, but the quality of evidence was considered very low because of the high risk of bias. In patients with familial adenomatous polyposis (FAP), Spigelman stage IV at initial endoscopy was considered a consistent risk factor in 3 studies. Conclusions: There are currently limited data regarding risk factors for non-ampullary duodenal adenocarcinoma, and no conclusive risk factors were identified in the general population. However, in patients with FAP, Spigelman stage IV was identified as a consistent risk factor. Further studies are needed to improve diagnosis and support effective clinical management of this malignancy.
AB - Introduction: An increase in the incidence of duodenal adenocarcinoma has been recently reported. However, little is known about the risk factors for duodenal adenocarcinoma, which are important for screening purposes. We, therefore, aimed to conduct a systematic review to identify risk factors for non-ampullary duodenal adenocarcinoma. Methods: A medical literature search was performed using electronic databases, including PubMed, Cochrane Library, Japan Medical Abstracts Society, and Web of Science. Studies that assessed the association between dietary habits, lifestyle behaviors, comorbidities, and non-ampullary duodenal adenocarcinoma were extracted. The Newcastle-Ottawa Scale was used to assess the risk of bias in individual studies, and the Grading of Recommendations, Assessment, Development, and Evaluations approach was used to assess the quality of evidence across studies included in this review. Results: Out of 1,244 screened articles, 10 were finally selected for qualitative synthesis. In the general population, no consistent risk factors were identified except for Helicobacter pylori positivity, which was considered a risk factor in 2 studies, but the quality of evidence was considered very low because of the high risk of bias. In patients with familial adenomatous polyposis (FAP), Spigelman stage IV at initial endoscopy was considered a consistent risk factor in 3 studies. Conclusions: There are currently limited data regarding risk factors for non-ampullary duodenal adenocarcinoma, and no conclusive risk factors were identified in the general population. However, in patients with FAP, Spigelman stage IV was identified as a consistent risk factor. Further studies are needed to improve diagnosis and support effective clinical management of this malignancy.
KW - Duodenal adenocarcinoma
KW - Familial adenomatous polyposis
KW - Risk factors
KW - Systematic review
UR - http://www.scopus.com/inward/record.url?scp=85124768324&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85124768324&partnerID=8YFLogxK
U2 - 10.1159/000516561
DO - 10.1159/000516561
M3 - Review article
AN - SCOPUS:85124768324
SN - 0257-2753
VL - 40
SP - 147
EP - 155
JO - Digestive Diseases
JF - Digestive Diseases
IS - 2
ER -